SMITHVILLE, Ohio — Levi Buxman is 11 years old. He has Down syndrome. And he just beat cancer. The fifth grader at Green Elementary in Smithville, a small Wayne County town, was diagnosed with B-cell ...

Katie has a PhD in maths, specializing in the intersection of dynamical systems and number theory. She reports on topics from maths and history to society and animals. Katie has a PhD in maths, ...

“Robert Mueller just died,” Trump posted on social media shortly after the death was first reported. “Good, I’m glad he’s dead. He can no longer hurt innocent people!” While it was the culmination of ...

Xeno Crisis is a top-down arcade style shooter taking inspiration from classics like Smash TV and Contra. Every few enemies killed will result in a set of dog-tags being dropped - these can be ...

WASHINGTON — A nationwide recall of multiple cheese products issued last year has been upgraded to the Food and Drug Administration’s most serious risk category after testing confirmed the presence of ...

A logical hat code can save nine out of ten people from an alien test that requires perfect reasoning. What a US destroyer shooting a cargo ship's engine out reveals about how the Navy is handling ...

We saw some exciting tech at CES this week, including new monitors leveraging NVIDIA's G-SYNC Pulsar technology. Now it's a waiting game to see when they'll actually be available to purchase. In the ...

Dell's modern Alienware gaming laptops are powerful and cool-looking machines, but they have a reputation of being hefty and expensive. That may soon change. At CES 2026 Monday, the American tech ...

Attributes determine the stats of your party members in Clair Obscur: Expedition 33. The most important thing you need to know about attributes is this: They make number go up. In this Clair Obscur: ...

1 Ambulatory Clinic, Department of Nutraceutical dNa Milano, Milan, Italy. 2 IMO Scientific Medical Department, Milan, Italy. The objective of this study was to report the clinical outcomes and DAO ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...